Literature DB >> 7418659

A membrane abnormality in lymphocytes from diabetic subjects.

H C Cheung, E C Almira, P C Kansal, W J Reddy.   

Abstract

The fluorescence properties of the hydrophobic probe 1,6-diphenyl1-1,3,5-hexatriene incorporated in the lymphocytes of 30 diabetic patients and 21 normal control subjects were studied. The mean value of the probe polarization was 0.314 for the control group and 0.294 for the patient group. The difference was significant at p < 0.001. The decreased polarization was correlated with the level of plasma glucose in the patients (p < 0.01). Nanosecond fluorescence results obtained from the lymphocytes of 7 patients and 5 controls indicated that there was no significant difference in the probe lifetimes between the two groups of subjects and suggest that the decreased polarization of the probe in the patient group resulted from a more fluid lipid environment of cell membranes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418659     DOI: 10.3109/07435808009065968

Source DB:  PubMed          Journal:  Endocr Res Commun        ISSN: 0093-6391


  4 in total

1.  Interferon inhibits Sendai virus-induced cell fusion: an effect on cell membrane fluidity.

Authors:  S Chatterjee; H C Cheung; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

2.  Increased single strand breaks in DNA of lymphocytes from diabetic subjects.

Authors:  M Lorenzi; D F Montisano; S Toledo; H C Wong
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

3.  Arachidonic acid deficiency in streptozotocin-induced diabetes.

Authors:  R T Holman; S B Johnson; J M Gerrard; S M Mauer; S Kupcho-Sandberg; D M Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

4.  The fluidity of plasma membranes from ethanol-treated rat liver.

Authors:  A Schüller; J Moscat; E Diez; C Fernandez-Checa; F G Gavilanes; A M Municio
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.